The observational evidence linking lower LCPFA status with depression is quite strong.
The published RCTs that have given extra LCPFA to counter depression have tended to small sample sizes and have had very varied methodologies. The trend is towards positive results, but we do not yet have enough data to be confident about what treatment will benefit which patient.